TABLE 2. Prevalence of metabolic syndrome and risk factorsa, 10–18 yearsa (n = 1228).
Condition | Total Sample | Male | Female | p value | ||||
---|---|---|---|---|---|---|---|---|
Frequency, n | % (95% CI) CV | Frequency | % (95% CI) CV | Frequency | % (95% CI) CV | |||
MetS | 25 | 2.1 (0.8–3.3) 0.29b | — | — | — | — | — | |
Number of risk factors | ||||||||
≥ 2 | 123 | 10.8 (7.4–14.2) 0.15 | 71 | 6.1 (3.5–8.7) 0.02 | 52 | 4.7 (2.8–6.5) 0.19 | .3658 | |
≥ 1 | 420 | 37.7 (33.8–41.6) 0.05 | 212 | 18.1 (15.4–20.8) 0.07 | 208 | 19.6 (16.4–22.9) 0.08 | .3179 | |
Abdominal obesity | 240 | 21.6 (16.6–26.7) 0.11 | 130 | 10.6 (7.3–13.9) 0.15 | 110 | 11.0 (7.5–14.5) 0.16b | .7443 | |
Low HDL–C | 218 | 19.1 (16.6–21.8) 0.06 | 107 | 8.8 (6.6–11.0) 0.12 | 111 | 10.54 (8.4–12.3) 0.09 | .2863 | |
Elevated triglycerides | 82 | 7.9 (4.8–11.0) 0.19b | 42 | 4.7 (2.2–7.3) 0.26b | 40 | 3.2 (1.7–7.2) 0.22b | ||
Elevated glucose | 22 | 1.7 (0.7–2.8) 0.30b | — | — | — | — | — |
Abbreviations: BP, blood pressure; CV, coefficient of variation; HDL-C, high-density lipoprotein cholesterol.
Note: Blank cells (—) indicate that the results cannot be published because of a cell size n < 10 and/or a CV ≥ 0.3306. The prevalence of elevated BP was too low to provide an accurate statistical estimate.
These figures are based on weighted data.
These figures are published with reservation as 0.16 ≤ CV ≥ 0.33.